Dewislen
Chwilio
er enghraifft swydd, cwmni, sgiliau
er enghraifft dinas, sir neu god post

4 cytundeb, rhan amser, swydd yn Chesterton, Cambridge

wedi’u postio yn y 30 diwrnod diwethaf
Dangos hidlwyr

Hyderus o ran Anabledd

Gweithio o bell

Lleoliad

Dyddiad hysbysebu

Ystod cyflog

Categori

Math o gytundeb

Oriau

Canlyniadau 1-4 o 4
Dangos fesul tudalen a didoli drwy

Sales Associate - H. Samuel - Temporary - Part Time

  • 18 June 2024
  • Signet Jewelers - Cambridge, CB2 3NA
  • Competitive salary plus bonuses, benefits & staff discount
  • Cytundeb
  • Rhan amser

Our Sales Associates help our customers Celebrate Life & Express Love Temporary Sales Associate - Part Time Our store teams are made up of customer-first people with a real passion for outstanding service, creating amazing experiences and lasting memories for ...

Flexible Nursery Practitioner

  • 17 June 2024
  • Kindred Education Ltd - Cambridgeshire, CB4 3EP
  • £11.44 to £11.50 per hour
  • Cytundeb
  • Rhan amser

JOIN THE UK'S NUMBER 1 NURSERY GROUP Are you an inspiring and caring individual interested to work according to your personal schedule? If so, a Flexible Nursery Practitioner role could be for you Working in a winning nursery, voted the UK's top nursery group ...

Flexible Nursery Practitioner

  • 07 June 2024
  • Kindred Education Ltd - Cambridgeshire, CB4 3EP
  • £11.44 to £11.50 per hour
  • Cytundeb
  • Rhan amser

JOIN THE UK'S NUMBER 1 NURSERY GROUP Are you an inspiring and caring individual interested to work according to your personal schedule? If so, a Flexible Nursery Practitioner role could be for you Working in a winning nursery, voted the UK's top nursery group ...

Fractional CSO/Advisor - mRNA biotech

  • 03 June 2024
  • Hays Specialist Recruitment - Cambridge, Cambridgeshire, CB2 0AA
  • £2,000.0 to £2,400.0 per day
  • £200-300 per hour
  • Yn gyfan gwbl o bell
  • Cytundeb
  • Rhan amser

Your new company You will be joining a breakthrough VC backed biotech who have recently raised a multi-million pound Seed funding round.They are pioneering novel treatments in the field of cancer immunoprevention and are currently developing a lead mRNA ...

  • 1